Trial Profile
Comparative Double Blind Placebo Controlled Clinical Study on Tocilizumab Rapid Efficacy on Patients Relief in rheumatoid Arthritis With an Inadequate Response to DMARDs or Anti TNF
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Apr 2022
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Acronyms TORPEDO
- Sponsors Roche
- 08 Aug 2012 Actual patient number changed from 99 to 103 as reported by ClinicalTrials.gov.
- 08 Aug 2012 Actual end date (1 Apr 2012) added as reported by ClinicalTrials.gov.
- 01 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.